The Company reaffirms its revenue guidance of $24-26 million for 2026.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDWD:
- MediWound management to meet with Maxim
- Is MDWD a Buy, Before Earnings?
- MediWound Shareholders Approve Expansion of 2024 Equity Incentive Pool
- MediWound Calls February 19, 2026 Extraordinary Meeting to Expand 2024 Share Incentive Plan
- Mediwound: NexoBrid Capacity Expansion and EscharEx Pipeline Catalysts Support Buy Rating and $36 Target